It has been shown that the PPARβ/δ agonist GW501560 increased VEGF expression in tumor cell lines [16] and promoted tumorigenesis in Apc(Min/+) mice [7,16] linking tumor cell growth and angiogenesis in the gut. Here, VEGFA is linked to neoplasm.